NC Puts 10 Companies on SEBIO Forum Stages
|Photo by Tim McKay|
Ten innovative North Carolina life science companies are among the 26 chosen to pitch technologies and plans Nov. 6 and 7 at the 2013 Southeast BIO Investor & Partnering Forum in Richmond, Virginia.
The event, co-sponsored by the North Carolina Biotechnology Center at the iconic Jefferson Hotel, provides a showcase for some of the most promising bioscience and medical technology companies in the seven-state region, which also includes Alabama, Florida, Georgia, South Carolina, Tennessee, and Virginia.
The event gives executives of young companies picked by a selection committee of regional and national venture capitalists a chance to collect advice and investment.
One group of companies, dubbed MAIN/Stage presenting companies, have generally completed at least one round of institutional financing. They will each make a 10-minute pitch to the full conference audience on Wednesday afternoon, November 6.
Companies in the EARLY/Stage event are seeking their first rounds of investment. They will participate in an individual private advisory session led by early-stage investors, entrepreneurs and experienced life science managers and service providers. Four EARLY/Stage companies will be selected to present to the full conference audience, with an overall "winner" announced at the closing lunch.
There's also a BIO/Plan competition with four contenders, one of which is PleX Diagnostics, a Triangle-area UNC spinout developing a diagnostic test for liver cancer. PleX and the other finalists will present their business opportunities to the audience and to a panel of celebrity judges. Judges will score the participants and add their scores to the earlier written development plan scores to determine the winner of the plan competition. The BIO/Plan winner will also be announced at the Closing Luncheon
NC companies giving MAIN/Stage presentations are:
- G1 Therapeutics of Chapel Hill, developing therapeutics to protect bone marrow from damage due to chemotherapy or radiation;
- Pique Therapeutics, of Durham, developing therapeutic vaccines to treat cancer.
EARLY/Stage presenters from NC include:
- Ardeal Pharma, of Brevard, developing treatments for dermal, pharmaceutical and cosmetic markets based on Stabilized Sulforaphane;
- Camras Vision of Research Triangle Park, developing personalized care treatment for glaucoma patients to stop vision loss;
- CanDiag of Charlotte, developing cancer screening technology for early detection of breast cancer;
- Eboo Pharmaceuticals of Durham, developing pharmaceutical compounds for Parkinson’s disease and other indications;
- NIRvana Sciences of RTP, developing novel dyes with ultra-narrow spectral properties;
- Novocor Medical Systems of Raleigh, developing a rapid-chilling device to induce therapeutic hypothermia;
- T3D Therapeutics of RTP, developing therapeutic to treat Alzheimer’s disease.
Registration remains open for the November event.